ICAM1 and acute lymphoblastic leukemia: Upon chemotherapy treatment for T-cell Acute Lymphoblastic Leukemia (T-ALL), T-ALL cells export mitochondria to MSCs via TNTs in an ICAM-1–mediated manner, reducing intracellular ROS and promotes chemoresistance: blocking TNTs formation or adhesion abolishes MSC-induced protection.